Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 26 studies. P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Closed to Follow Up P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants DAIDS Number 11882 Research Area Therapeutics Study Status Closed to Follow Up P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls DAIDS Number 11878 Research Area Brain and Mental Health Study Status Participants Off Study and Primary Analysis Completed P1100: AERAS 402 DAIDS Number 11801 Research Area Tuberculosis Study Status Concluded P1094: Evaluation of the use 3TC DAIDS Number 11769 Research Area Other Study Status Concluded P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded P1085: Human Papilloma Virus (HPV) Type-Specific Antibody DAIDS Number 10826 Research Area Other Study Status Concluded P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up Pagination Current page 1 Page 2 Page 3 Next page Next
P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Closed to Follow Up
P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants DAIDS Number 11882 Research Area Therapeutics Study Status Closed to Follow Up
P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls DAIDS Number 11878 Research Area Brain and Mental Health Study Status Participants Off Study and Primary Analysis Completed
P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics
P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded
P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded
P1085: Human Papilloma Virus (HPV) Type-Specific Antibody DAIDS Number 10826 Research Area Other Study Status Concluded
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up